A newer version of this article is available. Read the latest version
6 posts • GPT (4o mini)
Published
More breaking stories on DeepNewz — updated live.
🧬 News! @ProfluentBio’s latest large-scale AI systems for biological design are live: meet ProGen3. This work shows the first wet lab evidence of scaling benefits for biological design. The platform enables single-shot design of antibodies for 20 drug targets that address 7 https://t.co/Rs7U6U78ak
Ali and team at @ProfluentBio release ProGen3, showing: 1. scaling laws for generating biology with AI 2. emergent capabilities as models scale 3. single-shot design of antibodies for 20 drugs that have $660B in sales 4. design of a compact gene editor https://t.co/OM4tWaLDI0
What could scaling unlock for biology? Introducing ProGen3- our next AI foundation models for protein generation. We develop compute-optimal scaling laws up to 46B parameters on 1.5T tokens with real evidence in the wet lab. +we solve a new set of challenges for drug discovery https://t.co/VTXnzbF7bT
What if the same AI advancements that have transformed ChatGPT could be replicated in biology? Enter ProGen3, our latest foundation model suite for protein generation. https://t.co/4F9tnxhlMj
Exclusive: Biotech startup Profluent says it has discovered AI ‘scaling laws’ for AI models used in protein design https://t.co/MYkFnVVR62
Nvidia: Isomorphic Labs Rethinks Drug Discovery With AI - Isomorphic Labs is revolutionizing drug discovery by harnessing the power of AI! 🚀 Their innovative approach merges cutting-edge technology with biology, drastically speeding up the identificati… https://t.co/tSbKL2TpO6
🧬 News! @ProfluentBio’s latest large-scale AI systems for biological design are live: meet ProGen3. This work shows the first wet lab evidence of scaling benefits for biological design. The platform enables single-shot design of antibodies for 20 drug targets that address 7 https://t.co/Rs7U6U78ak
Ali and team at @ProfluentBio release ProGen3, showing: 1. scaling laws for generating biology with AI 2. emergent capabilities as models scale 3. single-shot design of antibodies for 20 drugs that have $660B in sales 4. design of a compact gene editor https://t.co/OM4tWaLDI0
